000650 仁和药业
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资30,628-5.47%32,40230,476030,006
投资性房地产24,917-5.15%26,26913,56820,17622,272
固定资产1,148,918-3.43%1,189,683899,129818,984524,632
在建工程257,96211.81%230,718345,430409,267580,582
无形资产306,186-2.31%313,437420,723582,867342,736
商誉501,9060.00%501,906546,910578,237606,124
其他非流动资产648,34876.07%368,231604,733644,383745,883
2,918,8659.62%2,662,6462,860,9703,053,9142,852,236

流动资产
货币资金952,945-59.08%2,328,6562,614,5292,825,4772,360,423
应收账款498,89336.41%365,723402,368348,271412,977
存货364,243-25.20%486,938446,579457,736601,352
其他流动资产3,131,88291.14%1,638,4961,120,235949,376680,904
4,947,9632.66%4,819,8144,583,7114,580,8594,055,656

流动负债
短期借款0--0000
应付票据250,000--0000
应付帐款157,82919.50%132,080123,501199,616176,075
其他流动负债464,382-7.91%504,265627,511964,895792,586
872,21137.07%636,345751,0121,164,511968,662
流动资产净值4,075,752-2.57%4,183,4683,832,6993,416,3483,086,994
资产总额减流动负债6,994,6172.17%6,846,1156,693,6706,470,2625,939,230

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债36,845-8.19%40,13239,16948,46412,338
36,845-8.19%40,13239,16948,46412,338

总权益
    实收股本1,399,9380.00%1,399,9381,399,9381,399,9381,399,938
    储备项目4,864,6161.90%4,773,7214,593,0994,340,8583,887,304
股东权益6,264,5541.47%6,173,6595,993,0375,740,7975,287,243
非控股权益693,2189.63%632,324661,464681,001639,650